Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
bullish
Vesync
Watchlist
Vesync (2148 HK) - 1Q24 Was Slow but End-Demand Is Healthy
Equity Bottom-Up
450 Views
26 Apr 2024 10:52
Broker
With an undemanding valuation of 7x FY24E P/E, we maintain BUY with a TP of HK$ 6.79, based on 11x P/E, well supported by 13%/16% sales/NP CAGRs during FY23-26E.
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 18-minute read)
Related Insights
More »
Vesync (2148 HK): 23rd April Scheme Vote. Done Deal
Vesync (2148 HK): Scheme Vote on 23 April
Vesync (2148 HK): What Did the FY24 Results Tell?
China Healthcare Weekly (Feb.9) - Vesync Is a High-Quality Company, VBP to Cover Retail Pharmacies
Vesync (2148 HK): Trading Wide Ahead Of The Scheme Vote
Trending Collections
More »
Index Rebalance
Equity Bottom-Up
Event-Driven
Japan
South Korea
China
India
Asia Event-Driven
Asia ECM
Sell / Short Ideas
Trending Insights
More »
MV Global Uranium & Nuclear Energy/Infra Index Rebalance: Double Inclusion for CGN Mining
MV Global Defense Industry Index Rebalance: US$1.1bn Round-Trip Trade as Stocks Soar
[Quiddity Index] MV Global Defense Jun25 Rebalance Results: Flow Expectations
Bank of Japan's June Policy Decision: A Non-Event for Markets?
MV Global Rare Earth/Strategic Metals Index Rebalance: One Add, One Delete & Other Changes
Top Unpaywalled Insights
More »
HK Connect SOUTHBOUND Flows (To 13 June 2025); Volumes Up, TECH Down, HEALTHCARE Bought Big
[IO Technicals 2025/24] Downward Momentum Lingers
China A-Share Consumer Staples: An Analysis of the Opportunities Ahead
Bearishness Persist in Soybeans Despite Rebound Hopes
Curator's Cut: The Next Labubu, Crypto Equities and Tracking APAC Buybacks
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Vesync (2148 HK) - 1Q24 Was Slow but End-Demand Is Healthy
26 Apr 2024
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x